The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exposure-response (ER) analyses of efficacy and safety of trastuzumab deruxtecan (T-DXd) to inform dosing recommendation in HER2-mutant non-small cell lung cancer (NSCLC).
 
Amit Khatri
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Daniel Polhamus
Consulting or Advisory Role - Employer is a CRO, our primary client base is the pharmaceutical space.
Research Funding - My salary is paid for by Metrum RG, a CRO in the pharmaceutical industry.
 
Enoch Cobbina
Employment - Daiichi Sankyo; Syndax
Stock and Other Ownership Interests - Syndax
 
Ramon Garcia
No Relationships to Disclose
 
Todd Yoder
Consulting or Advisory Role - Employer is a CRO, our primary client base is the pharmaceutical space
Research Funding - My salary is paid by Metrum RG, a CRO in the pharmaceutical industry
 
Malaz Abutarif
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Bristol-Myers Squibb; Daiichi Sankyo; JJ Innovative Medicine; Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Tushar Garimella
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo